Most Popular
1. Banking Crisis is Stocks Bull Market Buying Opportunity - Nadeem_Walayat
2.The Crypto Signal for the Precious Metals Market - P_Radomski_CFA
3. One Possible Outcome to a New World Order - Raymond_Matison
4.Nvidia Blow Off Top - Flying High like the Phoenix too Close to the Sun - Nadeem_Walayat
5. Apple AAPL Stock Trend and Earnings Analysis - Nadeem_Walayat
6.AI, Stocks, and Gold Stocks – Connected After All - P_Radomski_CFA
7.Stock Market CHEAT SHEET - - Nadeem_Walayat
8.US Debt Ceiling Crisis Smoke and Mirrors Circus - Nadeem_Walayat
9.Silver Price May Explode - Avi_Gilburt
10.More US Banks Could Collapse -- A Lot More- EWI
Last 7 days
Stock Market Volatility (VIX) - 25th Mar 24
Stock Market Investor Sentiment - 25th Mar 24
The Federal Reserve Didn't Do Anything But It Had Plenty to Say - 25th Mar 24
Stock Market Breadth - 24th Mar 24
Stock Market Margin Debt Indicator - 24th Mar 24
It’s Easy to Scream Stocks Bubble! - 24th Mar 24
Stocks: What to Make of All This Insider Selling- 24th Mar 24
Money Supply Continues To Fall, Economy Worsens – Investors Don’t Care - 24th Mar 24
Get an Edge in the Crypto Market with Order Flow - 24th Mar 24
US Presidential Election Cycle and Recessions - 18th Mar 24
US Recession Already Happened in 2022! - 18th Mar 24
AI can now remember everything you say - 18th Mar 24
Bitcoin Crypto Mania 2024 - MicroStrategy MSTR Blow off Top! - 14th Mar 24
Bitcoin Gravy Train Trend Forecast 2024 - 11th Mar 24
Gold and the Long-Term Inflation Cycle - 11th Mar 24
Fed’s Next Intertest Rate Move might not align with popular consensus - 11th Mar 24
Two Reasons The Fed Manipulates Interest Rates - 11th Mar 24
US Dollar Trend 2024 - 9th Mar 2024
The Bond Trade and Interest Rates - 9th Mar 2024
Investors Don’t Believe the Gold Rally, Still Prefer General Stocks - 9th Mar 2024
Paper Gold Vs. Real Gold: It's Important to Know the Difference - 9th Mar 2024
Stocks: What This "Record Extreme" Indicator May Be Signaling - 9th Mar 2024
My 3 Favorite Trade Setups - Elliott Wave Course - 9th Mar 2024
Bitcoin Crypto Bubble Mania! - 4th Mar 2024
US Interest Rates - When WIll the Fed Pivot - 1st Mar 2024
S&P Stock Market Real Earnings Yield - 29th Feb 2024
US Unemployment is a Fake Statistic - 29th Feb 2024
U.S. financial market’s “Weimar phase” impact to your fiat and digital assets - 29th Feb 2024
What a Breakdown in Silver Mining Stocks! What an Opportunity! - 29th Feb 2024
Why AI will Soon become SA - Synthetic Intelligence - The Machine Learning Megatrend - 29th Feb 2024
Keep Calm and Carry on Buying Quantum AI Tech Stocks - 19th Feb 24

Market Oracle FREE Newsletter

How to Protect your Wealth by Investing in AI Tech Stocks

British Billionaire Jim Mellon Says Biotech Is the Best Investment Now

Companies / BioTech Apr 05, 2017 - 03:27 PM GMT

By: John_Mauldin

Companies

BY PATRICK COX : We are in the midst of an unprecedented change. Life spans have nearly doubled since the beginning of the 20th century. In addition, recent advances in computer technology have had a huge impact on biological sciences, which means this trend will accelerate.

Still, most people think that the process of aging will go on pretty much as it is now. They’re wrong.


Discoveries have been made that will yield radical increases in healthy life expectancies. These biotechnologies will change everything— the way we live... and the way we invest. I write about the most promising of these breakthroughs in Tech Digest (subscribe here for free).

Longer, Healthier Life Spans Require Dramatic Change

Social security programs were implemented when almost no one lived past the age of 65.

Today, these programs won’t survive without radical restructuring. Pension programs designed using old actuarial tables will collapse. Healthcare, our largest financial sector, will barely resemble the current model.

Diseases we fear today will soon become minor issues, and companies that provide traditional treatments will be bankrupted. Why? Artificial intelligence and personalized genome analysis will be the norm.

The public is just starting catch on. Government policymakers and portfolio managers will have to adapt to this new reality. Then, the biotech sector will escape the ghetto status it too often suffers from.

That’s why I’m always on the lookout for signs that opinion leaders are waking up to the coming biotech revolution.

One of the most promising signs was when Silicon Valley’s wealthiest entrepreneurs embraced anti-aging research a few years back. (You might recall headlines like “6 Billionaires Who Want To Live Forever.”)

My impression, though, is that most people view Peter Thiel, Larry Ellison, and Larry Page as wealthy eccentrics. With so much money in their bank accounts, people think these men can afford to squander it on costly and unrealistic pet projects.

In fact, I haven’t been impressed by the way they’ve spent their money either. Instead of funding well-validated anti-aging compounds that could be ready in just a few years, they’ve started from scratch.

Some of the research funded by tech billionaires is interesting, but it won’t reach the market for a decade or two. That’s just too long for most people to take seriously.

Plus, we don’t have that much time to rescue Social Security and Medicare. If we don’t cut the cost of age-related disease and prolong healthy working careers soon, the entire system will collapse.

A New Voice Champions the Biotech Solution

British economist Jim Mellon is now beating the biotech drum. European readers are already well-acquainted with him. Mellon has made a billion dollars based on a long series of remarkably accurate financial predictions.

Though his name may not be as well known in the US, sophisticated financial analysts are aware of his track record. In fact, my boss, John Mauldin, is interested in many of the same issues and wrote an endorsement for Mellon’s latest book.

Mellon sees the big macroeconomic picture. Unlike the tech billionaires, he knows what demographic aging and plummeting birthrates are doing to government budgets in Europe and North America.

He also knows that anti-aging biotechnologies are the only way to fix those problems… which means these breakthroughs will eventually be embraced.

Europe’s aging problem is worse than the US’s, so it needs biotech solutions soon. Mellon’s views are getting traction on the continent, and that is very good news for us. It can only help spread the message across to our side of the Atlantic.

Stay in the Loop on Life-Extending Research with Patrick Cox's Tech Digest

This weekly newsletter by biotech expert Patrick Cox highlights research that is much more advanced than most people know, and the profit potential for investors is vast. Read about the latest breakthroughs—from new, non-invasive cancer treatments to age-reversing nutraceuticals and vaccines that kill any virus–as well as the innovative companies that work on them. Get Tech Digest free in your inbox every Monday.

John Mauldin Archive

© 2005-2022 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in